Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

BUY
$191.89 - $259.92 $37,994 - $51,464
198 Added 1.79%
11,239 $2.27 Million
Q4 2022

Feb 07, 2023

BUY
$197.11 - $250.07 $26,806 - $34,009
136 Added 1.25%
11,041 $2.4 Million
Q3 2022

Oct 20, 2022

BUY
$182.44 - $250.54 $14,595 - $20,043
80 Added 0.74%
10,905 $2.15 Million
Q2 2022

Jul 20, 2022

BUY
$204.13 - $302.4 $102,677 - $152,107
503 Added 4.87%
10,825 $2.32 Million
Q1 2022

Apr 21, 2022

BUY
$255.51 - $362.11 $267,774 - $379,491
1,048 Added 11.3%
10,322 $2.93 Million
Q4 2021

Jan 20, 2022

BUY
$351.38 - $448.68 $327,837 - $418,618
933 Added 11.19%
9,274 $3.49 Million
Q3 2021

Oct 13, 2021

SELL
$372.64 - $458.3 $65,957 - $81,119
-177 Reduced 2.08%
8,341 $3.44 Million
Q2 2021

Aug 02, 2021

BUY
$294.17 - $371.65 $1,765 - $2,229
6 Added 0.07%
8,518 $3.15 Million
Q1 2021

Apr 20, 2021

SELL
$249.67 - $299.48 $8,488 - $10,182
-34 Reduced 0.4%
8,512 $2.47 Million
Q4 2020

Feb 02, 2021

SELL
$222.0 - $252.62 $2,442 - $2,778
-11 Reduced 0.13%
8,546 $2.14 Million
Q3 2020

Nov 04, 2020

SELL
$175.56 - $226.45 $702 - $905
-4 Reduced 0.05%
8,557 $1.94 Million
Q2 2020

Jul 15, 2020

SELL
$118.84 - $189.72 $9,507 - $15,177
-80 Reduced 0.93%
8,561 $1.49 Million
Q1 2020

Apr 14, 2020

BUY
$98.9 - $178.34 $74,076 - $133,576
749 Added 9.49%
8,641 $1.09 Million
Q4 2019

Jan 27, 2020

BUY
$126.05 - $152.76 $21,680 - $26,274
172 Added 2.23%
7,892 $1.21 Million
Q3 2019

Oct 09, 2019

BUY
$125.07 - $143.67 $7,128 - $8,189
57 Added 0.74%
7,720 $1.02 Million
Q2 2019

Jul 09, 2019

BUY
$123.4 - $148.55 $945,614 - $1.14 Million
7,663 New
7,663 $1.09 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Capital Insight Partners, LLC Portfolio

Follow Capital Insight Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.